Table 3.
Electrocardiographic parameters
SCN5A+ | SCN5A−BrS+ (N = 39) | Controls (N = 38) | p‐value | ||
---|---|---|---|---|---|
BrS+ (N = 44) | BrS− (N = 35) | ||||
PR (ms) | 199 ± 28 | 186 ± 28 | 157 ± 22 | 151 ± 24 | <.001 a , b , c , d |
QRS (ms) | 117 ± 22 | 112 ± 15 | 106 ± 15 | 94 ± 10 | <.001 a , b , d , e |
RR (ms) | 919 ± 136 | 1010 ± 163 | 853 ± 164 | 917 ± 152 | <.001 a , b |
QTc (ms) | 416 ± 30 | 406 ± 20 | 405 ± 18 | 414 ± 21 | .071 |
filQRS (ms) | 136 ± 23 | 131 ± 16 | 123 ± 11 | 114 ± 10 | <.001 a , b , d |
RMS40 (μV) | 17 ± 12 | 20 ± 11 | 20 ± 9 | 37 ± 20 | <.001 b , d , e |
LAS40 (ms) | 52 ± 17 | 46 ± 13 | 42 ± 11 | 34 ± 11 | <.001 a , b , d |
LP ≥ 2/3 | 30 (68%) | 22 (63%) | 17 (44%) | 5 (13%) | <.001 b , d , e |
fQRS | 5 (11%) | 6 (17%) | 3 (8%) | 1 (3%) | .19 |
BrS, Brugada syndrome; filQRS, filtered QRS duration; fQRS, fragmented QRS; LAS40, duration of low amplitude signals < 40 μV; LP, late potentials; RMS40, root mean square of the last 40 ms of the QRS interval.
Bold p‐values indicate significant results.
p‐value Tukey post hoc test <.05 between SCN5A+BrS+ and SCN5A−BrS+.
p‐value Tukey post hoc test <.05 between SCN5A+BrS+ and controls.
p‐value Tukey post hoc test <.05 between SCN5A+BrS− and SCN5A−BrS+.
p‐value Tukey post hoc test <.05 between SCN5A+BrS− and controls.
p‐value Tukey post hoc test <.05 between SCN5A+BrS+ and SCN5A+BrS+.
p‐value Tukey post hoc test <.05 between SCN5A−BrS+ and controls.